Drug intelligence / Profile preview

morella cerifera pollen + sequoia sempervirens pollen + pinus banksiana pollen

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intradermal
01

Overview

A combination allergenic product composed of pollen extracts from Morella cerifera (wax myrtle), Sequoia sempervirens (coast redwood), and Pinus banksiana (jack pine). These pollen extracts are primarily used for allergy testing and possibly for allergen-specific immunotherapy, to diagnose or desensitize individuals with sensitivities to these tree pollens. Morella cerifera and Pinus banksiana pollen extracts are documented as allergenic extracts used in clinical allergy testing. Pollen from these species can provoke allergic reactions including rhinitis, conjunctivitis, or asthma in sensitized individuals. There is no evidence for pharmaceutical or non-allergenic therapeutic use of this combination, nor of a unique brand or code-named formulation. Each pollen’s extract may also have traditional uses: Morella cerifera extract has traditional medicinal uses (digestive, antimicrobial, astringent), but not specifically from pollen[1][4][13][19][22]. Pinus banksiana pollen is used for allergy testing[15]. Sequoia sempervirens pollen allergies are known, but clinical documentation of pollen use for diagnostic/allergenic purposes is limited.

Other names
wax myrtle pollen + coast redwood pollen + jack pine pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on morella cerifera pollen + sequoia sempervirens pollen + pinus banksiana pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morella cerifera pollen + sequoia sempervirens pollen + pinus banksiana pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call